antibioticsАнтибиотики и ХимиотерапияAntibiot Khimioter = Antibiotics and Chemotherapy0235-2990ООО «Издательство ОКИ»antibiotics-374Research ArticleВ ПОМОЩЬ ПРАКТИКУЮЩЕМУ ВРАЧУGUIDELINES FOR PRACTITIONERSАнализ спектра бактериальных патогенов, выделенных у пациентов с осложнёнными инфекциями кожи и мягких тканей, предположительно вызванными грамположительной или смешанной флорой, в странах Центральной и Восточной ЕвропыAnalysis of the Spectrum of Bacterial Pathogens Isolated from Patients with Complicated Skin and Soft Tissue Infections Presumably Due to Grampositive or Mixed Flora in the Countries of the Central and East EuropeХохловаВ. Н.KhokhlovaV. N.noemail@neicon.ruКарелинА. А.KarelinA. A.noemail@neicon.ruБелоцерковскийМ. В.BelotserkovskyM. V.noemail@neicon.ruСтецюкО. У.StetsukO. U.noemail@neicon.ruPSI CRO AG, Цуг, ШвейцарияРоссияPSI CRO AG, Zug, SwitzerlandRussian FederationСмоленская государственная медицинская академияРоссияSmolensk State Medical AcademyRussian Federation201113052020565-61929Copyright © Хохлова В.Н., Карелин А.А., Белоцерковский М.В., Стецюк О.У., 20202020Хохлова В.Н., Карелин А.А., Белоцерковский М.В., Стецюк О.У.Khokhlova V.N., Karelin A.A., Belotserkovsky M.V., Stetsuk O.U.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.antibiotics-chemotherapy.ru/jour/article/view/374

Проведён анализ данных, включающих результаты микробиологических исследований клинического материала, полученного у пациентов с осложнёнными инфекциями кожи и мягких тканей, в 6 странах Европы. Результаты анализа спектра бактериальных патогенов позволяют получить представление о микробном пейзаже и эффективно проводить клинические исследования новых антибактериальных препаратов.

The data on the microbiological investigation of clinical materials from patients with complicated skin and soft tissue infections in 6 European countries were analysed. The analysis of the bacterial pathogens spectrum provided the microbial view and efficient use of novel antimicrobials in clinical trials.

инфекции кожи и мягких тканеймикробиологические исследованияграмположительные микроорганизмыskin and soft tissue infectionsmicrobiological investigationgrampositive organismsReferencesСавельев В.С., Гельфанд Б.Р., Жуков А.В. с соавт. Хирургические инфекции кожи и мягких тканей. Российские национальные рекомендации. М.: Боргес, 2009.Савельев В.С., Гельфанд Б.Р., Жуков А.В. с соавт. Хирургические инфекции кожи и мягких тканей. Российские национальные рекомендации. М.: Боргес, 2009.Stevens D.L., Bisno A.L., Chambers H.F. et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections. Clin Infect Dis 2005, 41: 1373-1406.Stevens D.L., Bisno A.L., Chambers H.F. et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections. Clin Infect Dis 2005, 41: 1373-1406.Pallin D.J., Egan D.J., Pelletier A.J. et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008, 51: 291-298.Pallin D.J., Egan D.J., Pelletier A.J. et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008, 51: 291-298.Rogers R.L., Perkins J. Skin and soft tissue infections. Prim Care 2006, 33: 697-710.Rogers R.L., Perkins J. Skin and soft tissue infections. Prim Care 2006, 33: 697-710.Dryden M.S. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009, 34: Suppl 1: S2-7.Dryden M.S. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009, 34: Suppl 1: S2-7.Pulgar S., Mehra M., Quintana A., Kempel A. The epidemiology of hospitalized cases of skin and soft tissue infection in Europe. 18th European Congress of Clinical Microbiology and Infectious Diseases. 2008, Barcelona, Spain, Abstr. P821.Pulgar S., Mehra M., Quintana A., Kempel A. The epidemiology of hospitalized cases of skin and soft tissue infection in Europe. 18th European Congress of Clinical Microbiology and Infectious Diseases. 2008, Barcelona, Spain, Abstr. P821.Doern G.V., Jones R.N., Pfaller M.A. et al. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 1999; 34: 65-72.Doern G.V., Jones R.N., Pfaller M.A. et al. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 1999; 34: 65-72.Jones M.E., Schmitz F.J., Fluit A.C. et al. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance program. Eur J Clin Microbiol Infect Dis. 1999; 18: 403-408.Jones M.E., Schmitz F.J., Fluit A.C. et al. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance program. Eur J Clin Microbiol Infect Dis. 1999; 18: 403-408.Jones M.E., Karlowsky J.A., Draghi D.C. et al. Epidemiology and antibiotic susceptibility patterns of pathogens isolated from skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents. 2003; 22: 406-419Jones M.E., Karlowsky J.A., Draghi D.C. et al. Epidemiology and antibiotic susceptibility patterns of pathogens isolated from skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents. 2003; 22: 406-419Bowler P.G., Duerden B.I., Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14: 244-269.Bowler P.G., Duerden B.I., Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14: 244-269.Fung H.B., Chang J.Y., Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs. 2003; 63: 1459-1480.Fung H.B., Chang J.Y., Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs. 2003; 63: 1459-1480.Rennie R.P., Jones R.N., Mutnick A.H. et al. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003; 45: 287-293.Rennie R.P., Jones R.N., Mutnick A.H. et al. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003; 45: 287-293.Jodrá V.M., Pérez C.D., Soler L.S. et al. 2006. Results of the Spanish national nosocomial infection surveillance network (VICONOS) for surgery patients from January 1997 through December 2003. Am J Infect Control 2003; 34: 134-141.Jodrá V.M., Pérez C.D., Soler L.S. et al. 2006. Results of the Spanish national nosocomial infection surveillance network (VICONOS) for surgery patients from January 1997 through December 2003. Am J Infect Control 2003; 34: 134-141.May A.K., Stafford R.E., Bulger E.M. et al. Treatment of complicated skin and soft tissue infections. Surg Infect. 2009; 10: 5: 467-499.May A.K., Stafford R.E., Bulger E.M. et al. Treatment of complicated skin and soft tissue infections. Surg Infect. 2009; 10: 5: 467-499.Eron L.J., Lipsky B.A., Low D.E. et al. Expert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003; 52 Suppl 1: i3-17.Eron L.J., Lipsky B.A., Low D.E. et al. Expert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003; 52 Suppl 1: i3-17.Moet G.J., Jones R.N., Biedenbach D.J. et al. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007; 57: 7-13.Moet G.J., Jones R.N., Biedenbach D.J. et al. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007; 57: 7-13.Sader H.S., Mallick R., Kuznik A. et al. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections. Int J Antimicrob Agents. 2007; 30 : 6: 514-520.Sader H.S., Mallick R., Kuznik A. et al. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections. Int J Antimicrob Agents. 2007; 30 : 6: 514-520.Deresinski S. Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005; 40: 562-573.Deresinski S. Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005; 40: 562-573.Cosgrove S.E., Sakoulas G., Perencevich E.N. et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003; 36: 53-59.Cosgrove S.E., Sakoulas G., Perencevich E.N. et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003; 36: 53-59.U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Uncomplicated and complicated skin and skin structure infections: Developing antimicrobial drugs treatment. Rockville, MD., 1998.U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Uncomplicated and complicated skin and skin structure infections: Developing antimicrobial drugs treatment. Rockville, MD., 1998.Sjolund M., Kahlmeter G. Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis. 2008; 40: 11-12: 894-898.Sjolund M., Kahlmeter G. Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis. 2008; 40: 11-12: 894-898.Shittu A., Lin J., Morrison D., Kolawole D. Isolation and molecular characterization of multiresistant Staphylococcus sciuri and Staphylococcus haemolyticus associated with skin and soft tissue infections. J Med Microbiol. 2004; 53: Pt 1: 51-55.Shittu A., Lin J., Morrison D., Kolawole D. Isolation and molecular characterization of multiresistant Staphylococcus sciuri and Staphylococcus haemolyticus associated with skin and soft tissue infections. J Med Microbiol. 2004; 53: Pt 1: 51-55.Cornia P.B., Davidson H.L., Lipsky B.A. The evaluation and treatment of complicated skin and skin structure infections. Expert Opin Pharmacother. 2008; 9: 5: 717-730.Cornia P.B., Davidson H.L., Lipsky B.A. The evaluation and treatment of complicated skin and skin structure infections. Expert Opin Pharmacother. 2008; 9: 5: 717-730.Dhawan B., Gadepalli R., Kapil A. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India. Diagn Microbiol Infect Dis. 2009; 65: 2: 196-198.Dhawan B., Gadepalli R., Kapil A. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India. Diagn Microbiol Infect Dis. 2009; 65: 2: 196-198.Eagye K.J., Kim A., Laohavaleeson S. et al. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes? Surg Infect (Larchmt). 2009; 10: 4: 323-331.Eagye K.J., Kim A., Laohavaleeson S. et al. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes? Surg Infect (Larchmt). 2009; 10: 4: 323-331.Owens R.C. Jr, Lamp K.C., Friedrich L.V., Russo R. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin. Am J Med 2007; 120: 10: Suppl 1: S6-12.Owens R.C. Jr, Lamp K.C., Friedrich L.V., Russo R. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin. Am J Med 2007; 120: 10: Suppl 1: S6-12.Jauregui L.E., Babazadeh S., Seltzer E. et al. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. Clin Infect Dis 2005; 41: 10: 1407-1415.Jauregui L.E., Babazadeh S., Seltzer E. et al. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. Clin Infect Dis 2005; 41: 10: 1407-1415.European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2008. On-going surveillance of S.pneumoniae, S.aureus, E.coli, E.faecium, E.faecalis, K.pneumoniae, P.aeruginosa. http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdfEuropean Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2008. On-going surveillance of S.pneumoniae, S.aureus, E.coli, E.faecium, E.faecalis, K.pneumoniae, P.aeruginosa. http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdfLipsky B.A., Weigelt J.A., Gupta V., Killian A., Peng M.M. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol. 2007; 28: 11: 1290-1298.Lipsky B.A., Weigelt J.A., Gupta V., Killian A., Peng M.M. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol. 2007; 28: 11: 1290-1298.Weigelt J., Itani K., Stevens D. et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005; 49: 6: 2260-2266.Weigelt J., Itani K., Stevens D. et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005; 49: 6: 2260-2266.

The authors declare that there are no conflicts of interest present.